Drugs that do not represent value for money or are medically unproven may be increasingly reaching one of Europe’s largest pharmaceutical markets, according to research undertaken by Cambridge sociologist Professor Lawrence King.
New medical devices take a long time to reach the market – and many never make it. Jon Johnson, a researcher at Cambridge’s Institute for Manufacturing, is looking at ways of making the process of commercialisation more efficient.
From campus to community, the worlds of mental health research and medical practice are being brought together by a collaboration involving researchers, health and social care providers, and the patients themselves.
On 14 March, academics and members of the public gathered at Emmanuel College to hear a panel of distinguished speakers discuss their personal visions of future healthcare in an event sponsored by the Science AAAS as part of the Cambridge Science Festival.
Analysis of the FirstStop initiative reveals that the service saves money and improves quality of life.
Cambridge academic Dr Andrew Tucker champions a direct approach to challenging the homophobia that destroys so many lives in South Africa. He has helped to set up a hard-hitting healthcare campaign that encourages a radical change in attitudes within the country’s most deprived communities.
The fierce opposition to President Obama’s healthcare policy in the US and the challenges facing health reformists in post-communist Europe are to be examined at the University of Cambridge.
The plight of Binayak Sen, the Indian public health expert recently bailed from prison on controversial sedition charges, is symptomatic of the problems facing India’s adivasis (indigenous or tribal peoples), Cambridge University researchers have claimed.
A mobile phone app developed by Cambridge researchers that tracks how people behave during an epidemic could be used to limit disease spread.
New research highlights examples of medical care transformed by mobile networks.
© 2025 University of Cambridge